Recurrent Skin Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08828 | Vismodegib | 0 | Completed | 1 |
| DB00992 | Methyl aminolevulinate | 1 | Completed | 1 |
| DB01169 | Arsenic trioxide | 1 / 2 | Completed | 1 |
| DB04456 | Arsenous acid | 1 / 2 | Completed | 1 |
| DB00530 | Erlotinib | 1 / 2 | Withdrawn | 1 |
| DB06075 | Linsitinib | 1 / 2 | Withdrawn | 1 |
| DB11666 | Buparlisib | 2 | Terminated | 1 |
| DB01101 | Capecitabine | 2 | Terminated | 1 |
| DB01254 | Dasatinib | 2 | Completed | 1 |
| DB17833 | Dimericine | 2 | Completed | 1 |
| DB00317 | Gefitinib | 2 | Completed | 1 |
| DB09143 | Sonidegib | 2 | Terminated | 1 |
| DB00002 | Cetuximab | Not Available | Completed | 1 |
| DB01042 | Melphalan | Not Available | Withdrawn | 1 |